Panel: AI in rare disease
Cofounder & CEO, Mendelian
Rudy Benfredj is co-founder and CEO at Mendelian.co. He is a Computer Scientist graduated from Imperial College London with a degree in Engineering during which he worked under the supervision of Dr. Aldo Faisal in the bioengineering faculty and Prof. Marek Sergot, Head of the Logic and Artificial Intelligence department. Passionate about health, he moved to Tel Aviv to work at the Israeli med tech diagnostics company Healthy.io focusing on image recognition and remote diagnosis as an early team member. As a Product Manager he helped the company grow to get its FDA clearance.
Rudy also set up and curated the first TEDMED event in London at the Royal Albert Hall gathering 5000 attendees for a day of inspiring talks on “Imagining better health”. He then pursued a course on impactful problem solving as the youngest graduate at Singularity University at NASA Ames. At Mendelian, Rudy is in charge of the product design and manages the company’s day-to-day business.
Who is your hero and why?
I’m pretty impressed with Larry Brilliant, He participated, as a medical officer, in the World Health Organization (WHO) smallpox eradication program that in 1980 certified the global eradication of smallpox. I remember reading about his team went knocking on doors in the smallest most remote village of India for years.
Where is your favourite place in the world and why?
My mom’s, because of the food obviously.
What is your greatest achievement?
The one to come!
What is your wish for the future of rare disease?
To eradicate the diagnostic odyssey.